Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma.
作者信息
Sekiguchi Yasunobu, Tsutsumi Hiroki, Gomyo Ayumi, Kudo Masahisa, Iizaki Yoshie, Maseki Nobuo, Kawamura Machiko, Kobayashi Kazuhiko, Nishimura Yu, Kanda Hiroaki, Nitta Hideaki, Noguchi Masaaki, Kobayashi Hirofumi
机构信息
Department of Hematology, Saitama Cancer Center, Saitama, Japan.
Department of Clinical Laboratory Medicine, Saitama Cancer Center, Saitama, Japan.
出版信息
J Clin Exp Hematop. 2023;63(4):262-265. doi: 10.3960/jslrt.23043.
Abstract
摘要
Zotero 插件